Harold MD - NanoVibronix Chief Director

All Insiders . USA . 
Stock . NanoVibronix . Stakeholders . Insider . Harold MD
NAOV Stock  USD 3.26  0.19  6.19%   

Insider

Harold MD is Chief Director of NanoVibronix
Age 71
Phone914 233 3004
Webhttps://www.nanovibronix.com

NanoVibronix Management Efficiency

The company has return on total asset (ROA) of (0.2651) % which means that it has lost $0.2651 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.9409) %, meaning that it created substantial loss on money invested by shareholders. NanoVibronix's management efficiency ratios could be used to measure how well NanoVibronix manages its routine affairs as well as how well it operates its assets and liabilities.
NanoVibronix currently holds 5 K in liabilities with Debt to Equity (D/E) ratio of 0.01, which may suggest the company is not taking enough advantage from borrowing. NanoVibronix has a current ratio of 3.01, suggesting that it is liquid enough and is able to pay its financial obligations when due. Note, when we think about NanoVibronix's use of debt, we should always consider it together with its cash and equity.

Similar Executives

Showing other executives

INSIDER Age

Mark KnudsonReShape Lifesciences
76
Dagi BenNoonInspira Technologies Oxy
49
Shunichi KurodaBone Biologics Corp
N/A
Rob ScottNuwellis
N/A
Katherine TwedenReShape Lifesciences
64
Nikolai KabelevSTRATA Skin Sciences
48
Sandra EayrsNuwellis
N/A
Mark MDBluejay Diagnostics
N/A
Julie GannonVivos Therapeutics
N/A
Kirk HuntsmanVivos Therapeutics
66
Jason CookBluejay Diagnostics
43
Danielle WatsonHeart Test Laboratories
43
Bradford AmmanVivos Therapeutics
63
Robert CarlsonBiomerica
N/A
Udi MDInspira Technologies Oxy
41
Todd HuntsmanVivos Therapeutics
N/A
DVM DVMReShape Lifesciences
N/A
Veronica CaiTivic Health Systems
48
John WilsonRapid Micro Biosystems
57
Hans BoehringerBiomerica
N/A
RaeAnn ByrnesVivos Therapeutics
N/A
NanoVibronix, Inc., through its subsidiary, NanoVibronix Ltd., focuses on the manufacture and sale of noninvasive biological response-activating devices that target biofilm prevention, wound healing, and pain therapy. NanoVibronix, Inc. was incorporated in 2003 and is based in Elmsford, New York. Nanovibronix operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 12 people. NanoVibronix (NAOV) is traded on NASDAQ Exchange in USA. It is located in 525 Executive Boulevard, Elmsford, NY, United States, 10523 and employs 10 people. NanoVibronix is listed under Medical Equipment category by Fama And French industry classification.

Management Performance

Return On Equity-0.94
Return On Asset-0.27

NanoVibronix Leadership Team

Elected by the shareholders, the NanoVibronix's board of directors comprises two types of representatives: NanoVibronix inside directors who are chosen from within the company, and outside directors, selected externally and held independent of NanoVibronix. The board's role is to monitor NanoVibronix's management team and ensure that shareholders' interests are well served. NanoVibronix's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, NanoVibronix's outside directors are responsible for providing unbiased perspectives on the board's policies.
CPA CPA, CFO Officer
M Harrison, VP Sales
Brian Murphy, CEO, Director
Amir Rippel, Vice Marketing
Stephen CPA, Chief Officer
Harold MD, Chief Director
Lindsey Harrison, Vice Sales

NanoVibronix Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is NanoVibronix a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Return On Equity-0.94
Return On Asset-0.27
Profit Margin(0.94) %
Operating Margin(2.58) %
Current Valuation1.4 M
Shares Outstanding792.39 K
Shares Owned By Insiders0.95 %
Shares Owned By Institutions1.99 %
Number Of Shares Shorted95.67 K
Price To Earning(5.34) X

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for NanoVibronix Stock Analysis

When running NanoVibronix's price analysis, check to measure NanoVibronix's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy NanoVibronix is operating at the current time. Most of NanoVibronix's value examination focuses on studying past and present price action to predict the probability of NanoVibronix's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move NanoVibronix's price. Additionally, you may evaluate how the addition of NanoVibronix to your portfolios can decrease your overall portfolio volatility.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY